Stock Screener App

Frei -

Installieren

1.91

7.30% 0.13

Sellas Life Sciences Group Inc (SLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SLS? Forum Prognose Aktiensplit

Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Selling, General, and Administrative	5.04% 3.002	2.858	2.481	2.967	2.435
Costs And Expenses	13.36% 6.873	6.063	6.918	7.329	7.621
Operating Income/Loss	13.36% -6.873	-6.063	-6.918	-7.329	-7.621
Nonoperating Income/Loss	8.80% 0.272	0.25	0.181	0.221	0.151
Income/Loss From Continuing Operations Before Tax	13.36% -6.873	-6.063	-6.286	-7.329	-7.621
Income/Loss From Continuing Operations After Tax	13.56% -6.601	-5.813	-6.737	-7.108	-7.47
Net Income/Loss	13.56% -6.601	-5.813	-6.737	-7.108	-7.47
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	12.30% 98.56	87.76	4.2618	68.25	57.63
Diluted Average Shares	12.30% 98.56	87.76	4.2618	68.25	57.63
Basic Earnings Per Share	0.00% -0.07	-0.07	-0.08	-0.10	-0.13
Diluted Earnings Per Share	0.00% -0.07	-0.07	-0.08	-0.10	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters